@_PSSD @DrHannahBelcher @IASPorguk @ItsEmilyKaty FWIW, prenatal SSRI-autism associations are probably due to confounding. Well-designed epidemiologic studies like the ones below fail to find a link: https://t.co/i0NPwiUi8U https://t.co/rq6VePwglK https://t.co/82Dhiql3B5 Don't believe me? The scientific consensus even as
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2021 – Sep 2024Where it's discussed
-
News12 articles
-
X / Twitter4 posts
-
Blogs4 articles
-
YouTube2 videos
AI synopsis
What people are saying
Discussions highlight the consensus that prenatal SSRI use is unlikely to significantly increase autism risk, with users pointing out that well-designed epidemiological studies do not support a link. The tone is analytical and evidence-based, with phrases like 'fail to find a link' and 'confounding,' reflecting a collective effort to interpret research critically and underscore the importance of scientific rigor.
Most posts show support for the study's findings, emphasizing that SSRI use during pregnancy is not strongly linked to neurodevelopmental risks, aligning with the article's conclusions.
Discussions express moderate curiosity, referencing epidemiologic studies and scientific consensus, indicating an engaged yet cautious interest in the topic.
Commenters quote and analyze research findings, mentioning terms like 'confounding,' 'well-designed studies,' and 'scientific consensus,' pointing to an active level of engagement.
The discussions promote reconsideration of assumptions about SSRIs and neurodevelopmental risks, suggesting the publication influences opinions and encourages reliance on epidemiologic evidence.
Abstract in brief
- This study investigates how maternal psychiatric disorders and SSRI use during preconception and pregnancy may affect the risk of neurodevelopmental disorders, specifically autism spectrum disorder (ASD) and developmental delays (DDs), in children.
- Using data from a case-control study of children born between 2003 and 2011, researchers found that mothers of children with ASD or DDs were more likely to have psychiatric conditions or use SSRIs during pregnancy compared to population controls.
- The results suggested that maternal psychiatric conditions increase the risk of ASD and DDs, but SSRI use did not show a significant association with these disorders, even among mothers with psychiatric conditions.
Top posts
Most liked on X and Blueskyhttps://t.co/G065KZkpaB
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders https://t.co/QXFAPwfQib #PubMed #Autism
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders - Biological Psychiatry https://t.co/VgXapwpuy2
All mentions
Antidepressant Use During Pregnancy and Risks for Autism and Developmental Delays
Antidepressants during pregnancy may pose risks; untreated depression could be linked to autism spectrum disorder and developmental delays. The study explores maternal psychiatric conditions, SSRI use, and their impact…
Safety of Antidepressants During Pregnancy and Impact on Child Development
This video explores the safety of antidepressants during pregnancy, focusing on maternal psychiatric disorders and the potential impact of SSRI use on neurodevelopmental disorders like autism spectrum disorder and…
@_PSSD @DrHannahBelcher @IASPorguk @ItsEmilyKaty FWIW, prenatal SSRI-autism associations are probably due to confounding. Well-designed epidemiologic studies like the ones below fail to find a link: https://t.co/i0NPwiUi8U https://t.co/rq6VePwglK https://t.co/82Dhiql3B5 Don't believe me? The scientific consensus even as
https://t.co/G065KZkpaB
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders - Biological Psychiatry https://t.co/VgXapwpuy2
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders https://t.co/QXFAPwfQib #PubMed #Autism